TradingKey

mehr Informationen über SelectQuote Inc Unternehmen

SelectQuote, Inc. provides a technology-enabled, direct-to-consumer (DTC) distribution and engagement platform for selling insurance policies and healthcare services. The Company has four core business lines: SelectQuote Senior, SelectQuote Healthcare Services, SelectQuote Life, and SelectQuote Auto and Home. SelectQuote’s Senior division sells Medicare Advantage, Medicare Supplement, Medicare Part D, and other ancillary senior health insurance related products. SelectQuote Healthcare Services comprises the SelectRx Pharmacy, a specialized medication management pharmacy, and Population Health which proactively connects its members with healthcare services that fit each member's healthcare needs. SelectQuote’s Auto & Home division primarily sells non-commercial auto and home, property and casualty insurance products. SelectQuote’s Life division sells term life, final expense, and other ancillary products. SelectRx is a Patient-Centered Pharmacy Home (PCPH) accredited pharmacy.

Unternehmensinformationen

BörsenkürzelSLQT

Name des UnternehmensSelectQuote Inc

IPO-datumMay 21, 2020

CEOMr. Timothy Robert (Tim) Danker

Anzahl der mitarbeiter1335

WertpapierartOrdinary Share

GeschäftsjahresendeMay 21

Addresse6800 West 115Th Street

StadtOVERLAND PARK

BörseNYSE Consolidated

LandUnited States of America

Postleitzahl66211

Telefon19132741994

Websitehttps://ir.selectquote.com/investor-home/default.aspx

BörsenkürzelSLQT

IPO-datumMay 21, 2020

CEOMr. Timothy Robert (Tim) Danker

Führungskräfte

Name

Name/Position

Position

Aktienbesitz

Veränderung

Mr. Robert Clay (Bob) Grant

President

4.32M

+10.97%

Mr. Timothy Robert (Tim) Danker

Chief Executive Officer, Director

2.63M

+21.12%

Ms. Denise L. Devine, CPA

Independent Director

318.58K

+1.27%

Dr. Kavita K. Patel, M.D.

Independent Director

310.58K

+43.99%

Mr. Ryan Moore Clement

Chief Financial Officer

304.70K

+95.99%

Ms. Sarah Anderson

Executive Vice President - Pharmacy Services

51.63K

+586.59%

Mr. Sloan Bohlen

Investor Relations

--

Mr. William Thomas Grant, III

Chief Operating Officer

--

Ms. Stephanie D. Fisher

Chief Accounting Officer

--

Mr. Raymond F. Weldon

Independent Director

--

Name

Name/Position

Position

Aktienbesitz

Veränderung

Mr. Robert Clay (Bob) Grant

President

4.32M

+10.97%

Mr. Timothy Robert (Tim) Danker

Chief Executive Officer, Director

2.63M

+21.12%

Ms. Denise L. Devine, CPA

Independent Director

318.58K

+1.27%

Dr. Kavita K. Patel, M.D.

Independent Director

310.58K

+43.99%

Mr. Ryan Moore Clement

Chief Financial Officer

304.70K

+95.99%

Ms. Sarah Anderson

Executive Vice President - Pharmacy Services

51.63K

+586.59%

Umsatzaufteilung

Währung: USDAktualisiert: Sun, Jul 6

FY2025Q3

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2021

FY2020

FY2019

Nach GeschäftsbereichUSD

Name

Umsatz

Anteil

Commission

193.16M

47.32%

Pharmacy revenue

185.27M

45.39%

Production bonus and other revenue

29.73M

7.28%

Keine Daten

Nach Geschäftsbereich

Nach Region

Nach GeschäftsbereichUSD

Name

Umsatz

Anteil

Commission

193.16M

47.32%

Pharmacy revenue

185.27M

45.39%

Production bonus and other revenue

29.73M

7.28%

Aktionärsstatistik

Aktualisiert: an hour ago

Aktionäre

Aktionärstypen

Aktionäre

Anteil

Brookside Equity Partners LLC

10.24%

BlackRock Institutional Trust Company, N.A.

5.33%

The Vanguard Group, Inc.

4.75%

Abrams Bison Investments, L.L.C.

4.58%

Mariner Wealth Advisors

3.69%

Andere

71.41%

Aktionäre

Anteil

Brookside Equity Partners LLC

10.24%

BlackRock Institutional Trust Company, N.A.

5.33%

The Vanguard Group, Inc.

4.75%

Abrams Bison Investments, L.L.C.

4.58%

Mariner Wealth Advisors

3.69%

Andere

71.41%

Aktionärstypen

Aktionäre

Anteil

Investment Advisor

20.48%

Investment Advisor/Hedge Fund

13.39%

Individual Investor

11.53%

Private Equity

10.24%

Hedge Fund

7.49%

Research Firm

2.13%

Corporation

0.63%

Pension Fund

0.43%

Bank and Trust

0.39%

Andere

33.29%

Institutionelle Beteiligung

Aktualisiert: Tue, Aug 5

Berichtszeitraum

Anzahl der Institutionen

Gehaltenen Aktien

Anteil

Veränderung

2025Q2

332

110.44M

63.96%

+4.81M

Aktionärsaktivitäten

Name

Gehaltenen Aktien

Anteil

Veränderung

Änderung%

Datum

Keine Daten

Verbundene ETFs

Aktualisiert: Wed, Aug 6

Name

Anteil

iShares FinTech Active ETF

1.05%

iShares Micro-Cap ETF

0.07%

Avantis US Small Cap Equity ETF

0.05%

Fidelity Enhanced Small Cap ETF

0.05%

Invesco RAFI US 1500 Small-Mid ETF

0.02%

iShares Russell 2000 Growth ETF

0.02%

Goldman Sachs ActiveBeta US Small Cap Equity ETF

0.02%

Avantis US Small Cap Value ETF

0.02%

iShares US Small-Cap Equity Factor ETF

0.01%

Global X Russell 2000 ETF

0.01%

iShares FinTech Active ETF

Anteil1.05%

iShares Micro-Cap ETF

Anteil0.07%

Avantis US Small Cap Equity ETF

Anteil0.05%

Fidelity Enhanced Small Cap ETF

Anteil0.05%

Invesco RAFI US 1500 Small-Mid ETF

Anteil0.02%

iShares Russell 2000 Growth ETF

Anteil0.02%

Goldman Sachs ActiveBeta US Small Cap Equity ETF

Anteil0.02%

Avantis US Small Cap Value ETF

Anteil0.02%

iShares US Small-Cap Equity Factor ETF

Anteil0.01%

Global X Russell 2000 ETF

Anteil0.01%

Dividende

In den vergangenen 5 Jahren wurden insgesamt 0.00 USD an Dividenden ausgeschüttet.

Datum

Dividende

Stichtag für die Aktienregistrierung

Zahltag

Ex-Dividendentag

Keine Daten

Aktien-Split

Datum

Art

Verhältnis

Keine Daten

Datum

Art

Verhältnis

Keine Daten

SelectQuote Inc

1.940USD

SelectQuote Inc

1.940

Übersicht

Unternehmen

Finanzen